P

PTC Therapeutics

Biopharmaceuticals for rare genetic disorders

Director, Clinical Development

Biology & BiotechConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • An MD degree and at least 2 years of clinical drug development experience in a pharmaceutical, biotechnology, or related environment are required.
  • Demonstrated experience managing one or more global clinical programs is required.
  • Knowledge of the pharmaceutical and biotechnology industry, global drug development and regulatory processes, research and development, key clinical milestones, and factors influencing critical development and decision-making points is required.
  • Demonstrated expertise in clinical trial design, conduct, and interpretation of clinical data is required.
  • Previous experience with regulatory submissions is required.
  • Proficiency with Microsoft Office is required.
  • Ability to work independently and collaboratively in a fast-paced, matrixed environment with internal and external team members is required.
  • Ability to travel domestically and internationally is required.

Responsibilities

  • Provide tactical oversight for the clinical and medical aspects of all phases of the clinical drug development process.
  • Contribute to the design, development, and execution of Clinical Development Plans, clinical trials, and protocols in accordance with Good Clinical Practice regulations.
  • Lead and contribute to the analysis of study results, assess whether studies achieved clinical, regulatory, and commercial objectives, and document study results.
  • As needed, serve as the primary clinical and medical representative in meetings with external stakeholders, partners, and audiences, including key opinion leaders, investigators, regulatory authorities, partners, vendors, and consultants; author or review clinical and medical materials for external audiences as needed.
  • Work cross-functionally with internal departments and external resources on Clinical Development issues.
  • Ensure adherence to relevant regulatory requirements and company Standard Operating Procedures.
  • Contribute to, review, and approve study protocols, protocol amendments, study manuals, Investigator Brochures, Clinical Study Reports, Informed Consent Forms, Case Report Forms, and other clinical documents needed for clinical trials.
  • Approve investigator sites for inclusion in studies, plan and facilitate investigator meetings, and present selected agenda sections or content.
  • Prepare weekly and/or monthly study update reports containing enrollment data, adverse events, and other information about study progress.
  • Interpret, summarize, and document clinical data for Clinical Study Reports, regulatory documents such as INDs, Annual Reports, NDAs, and MAAs, manuscripts, promotional material, and other publications.
  • Approve and monitor clinical study timelines.
  • Contribute to vendor selection and manage PTC's relationships with certain external vendors, partners, and investigators.
  • Represent the clinical study team at cross-functional, integrated team meetings as needed.
  • Participate in clinical review and recommendations regarding new opportunities, such as target selections or clinical due diligence.
  • Provide clinical and medical input to non-clinical and commercial functions.
  • Perform other tasks and assignments as needed and specified by management.

Desired Qualifications

  • Board certification or equivalent in a medical or clinical specialty is preferred.
  • Experience working in rare or orphan disease clinical development is preferred.

About the Company

PTC Therapeutics

Biopharmaceuticals for rare genetic disorders

PTC Therapeutics develops and commercializes treatments for rare genetic disorders worldwide, leveraging RNA biology and post-transcriptional control. Its portfolio includes Translarna (ataluren) for nonsense-mutant Duchenne muscular dystrophy, Evrysdi (risdiplam) for spinal muscular atrophy, Emflaza (deflazacort) for DMD, and Upstaza for AADC deficiency, among others. The company uses an integrated model spanning discovery, clinical development, manufacturing, and global commercialization, with operations in 50+ countries and a European base in Dublin. Its goal is to provide safe, effective therapies for patients with limited treatment options and to grow a robust pipeline in rare diseases.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Warren Township, New Jersey
Founded
1998

Recently Posted Jobs

Explore more opportunities at PTC Therapeutics

See more jobs